Related Experiment Video
Updated: Feb 6, 2026

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
MicroRNA-449a suppresses hepatocellular carcinoma cell growth via G1 phase arrest and the HGF/MET c-Met pathway
Jun Cheng1, Li-Ming Wu2, Xue-Song Deng1
1Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen 518035, China.
Background:
Accumulating evidence demonstrates that microRNAs (miRNAs) play essential roles in tumorigenesis and cancer progression of hepatocellular carcinoma (HCC). Average targets of a miRNA were more than 100. And one miRNA may act in tumor via regulating several targets. The present study aimed to explore more potential targets of miR-449a by proteomics technology and further uncover the role of miR-449a in HCC tumorigenesis.
Methods:
Technologies such as iTRAQ-based quantitative proteomic were used to investigate the effect of miR-449a on HCC. The expression of c-Met and miR-449a was detected by qRT-PCR in HCC samples. Gain- and loss-of-function experiments were performed to identify the function and potential target of miR-449a in HCC cells.
Results:
In HCC, miR-449a was significantly downregulated, while c-Met was upregulated concurrently. Quantitative proteomics and luciferase reporter assay identified c-Met as a direct target of miR-449a. Moreover, miR-449a inhibited HCC growth not only by targeting CDK6 but also by suppressing c-Met/Ras/Raf/ERK signaling pathway. Furthermore, the inhibition of c-Met expression with a specific siRNA significantly inhibited cells growth and deregulated the ERK pathway in HCC.
Conclusion:
The tumor suppressor miR-449a suppresses HCC tumorigenesis by repressing the c-Met/ERK pathway.
Insights
MicroRNA-449a (miR-449a) acts as a tumor suppressor in hepatocellular carcinoma (HCC). It inhibits HCC growth by targeting c-Met and repressing the c-Met/ERK pathway, offering potential therapeutic strategies for liver cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- MicroRNAs (miRNAs) are crucial in hepatocellular carcinoma (HCC) development and progression.
- HCC involves complex regulatory networks with single miRNAs targeting multiple genes.
- Identifying novel miRNA targets is key to understanding HCC tumorigenesis.
Purpose of the Study:
- To investigate potential targets of miR-449a in HCC using proteomics.
- To elucidate the role of miR-449a in HCC tumorigenesis and its regulatory mechanisms.
Main Methods:
- iTRAQ-based quantitative proteomics to analyze protein expression changes.
- Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) for gene expression analysis.
- Gain- and loss-of-function experiments in HCC cells to determine miR-449a function and targets.
Main Results:
- miR-449a was downregulated, and c-Met was concurrently upregulated in HCC.
- Proteomics and luciferase assays confirmed c-Met as a direct miR-449a target.
- miR-449a suppressed HCC growth by targeting CDK6 and inhibiting the c-Met/Ras/Raf/ERK pathway.
Conclusions:
- miR-449a functions as a tumor suppressor in HCC.
- Repression of the c-Met/ERK pathway by miR-449a inhibits HCC progression.
Related Concept Videos
MicroRNAs
MicroRNAs
C4 Pathway and CAM
C4 Pathway
The C4 pathway is used by plants such as...
Phase Diagrams
Phase Transitions
Cells Coordinate Growth and Proliferation

